Table 2.

Serum AEA and 2-AG Levels in Patients Undergoing MHD Stratified by Demographic and Clinical Characteristics

Subgroup	Endocannabinoids
	Serum AEA (pmol/mL) n = 50		Serum 2-AG (pmol/mL) n = 96
	Median (IQR)	P Value	Median (IQR)	P Value
Age, y
<50	0.98 (0.82–1.16)	0.37	73 (51–161)	0.73
≥50	1.05 (0.82–1.29)		78 (48–165)
Sex
Female	0.96 (0.76–1.29)	0.19	81 (53–177)	0.25
Male	1.05 (0.95–1.43)		75 (44–127)
Race
White	1.00 (0.89–1.33)	0.38	80 (48–172)	0.19
Asian	0.88 (0.76–1.29)		67 (51–101)
Ethnicity
Hispanic	0.98 (0.89–1.26)	0.78	83 (52–216)	0.13
Non-Hispanic	1.05 (0.76–1.35)		73 (48–127)
Dialysis vintage, d
<1095	0.99 (0.82–1.29)	0.62	96 (51–172)	0.42
≥1095	1.02 (0.83–1.33)		72 (48–144)
Presence of diabetes
Yes	0.98 (0.88–1.53)	0.43	78 (48–174)	0.63
No	1.01 (0.77–1.17)		75 (49–142)

Data are presented as median (IQR).